IMMX logo

IMMX
Immix Biopharma Inc

4,502
Mkt Cap
$490.45M
Volume
399,472.00
52W High
$11.61
52W Low
$1.56
PE Ratio
-10.40
IMMX Fundamentals
Price
$9.26
Prev Close
$9.75
Open
$9.78
50D MA
$8.39
Beta
1.31
Avg. Volume
867,781.43
EPS (Annual)
-$0.893
P/B
5.23
Rev/Employee
$0.00
$73.07
Loading...
Loading...
News
all
press releases
Immix Biopharma (NASDAQ:IMMX) Trading 12% Higher - Should You Buy?
Immix Biopharma (NASDAQ:IMMX) Stock Price Up 12% - Still a Buy...
MarketBeat·2d ago
News Placeholder
More News
News Placeholder
Immix Biopharma, Inc. (NASDAQ:IMMX) Receives Average Rating of "Moderate Buy" from Brokerages
Immix Biopharma, Inc. (NASDAQ:IMMX - Get Free Report) has earned a consensus recommendation of "Moderate Buy" from the six brokerages that are currently covering the stock, MarketBeat reports. One...
MarketBeat·9d ago
News Placeholder
Immix Biopharma (NASDAQ:IMMX) Stock Price Expected to Rise, Mizuho Analyst Says
Mizuho raised their target price on shares of Immix Biopharma from $14.00 to $15.00 and gave the company an "outperform" rating in a research note on Monday...
MarketBeat·12d ago
News Placeholder
Immix Biopharma (NASDAQ:IMMX) Issues Quarterly Earnings Results
Immix Biopharma (NASDAQ:IMMX - Get Free Report) announced its quarterly earnings results on Wednesday. The company reported ($0.28) earnings per share for the quarter, missing analysts' consensus...
MarketBeat·15d ago
News Placeholder
Citizens Jmp Reaffirms Market Outperform Rating for Immix Biopharma (NASDAQ:IMMX)
Citizens Jmp restated a "market outperform" rating and set a $23.00 price target on shares of Immix Biopharma in a research report on Friday...
MarketBeat·15d ago
News Placeholder
Immix Biopharma (NASDAQ:IMMX) Given New $15.00 Price Target at HC Wainwright
HC Wainwright lifted their price objective on shares of Immix Biopharma from $12.00 to $15.00 and gave the stock a "buy" rating in a research note on Friday...
MarketBeat·15d ago
News Placeholder
Immix Biopharma (NASDAQ:IMMX) Now Covered by Analysts at Morgan Stanley
Morgan Stanley began coverage on shares of Immix Biopharma in a research note on Wednesday. They set an "overweight" rating and a $20.00 price objective for the company...
MarketBeat·17d ago
News Placeholder
Immix Biopharma (NASDAQ:IMMX) Shares Down 8.9% - Should You Sell?
Immix Biopharma (NASDAQ:IMMX) Trading Down 8.9% - What's Next...
MarketBeat·24d ago
News Placeholder
Immix Biopharma (NASDAQ:IMMX) Trading Up 6.3% - What's Next?
Immix Biopharma (NASDAQ:IMMX) Trading Up 6.3% - Should You Buy...
MarketBeat·25d ago
News Placeholder
Short Interest in Immix Biopharma, Inc. (NASDAQ:IMMX) Drops By 13.4%
Immix Biopharma, Inc. (NASDAQ:IMMX - Get Free Report) was the target of a significant decrease in short interest during the month of February. As of February 27th, there was short interest totaling...
MarketBeat·25d ago
<
1
2
...
>

Latest IMMX News

View
Top Discussions

Advertisement|Remove ads.

Advertisement|Remove ads.